Author

Mohamed F. Zaky

Institution: Egyptian Russian University

Observed institution: Egyptian Russian University

ORCID: 0000-0001-9230-2847

Observed ORCID: 0000-0001-9230-2847

OpenAlex ID: A5065965323

Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity

2022 · Mohamed F. Zaky, Mohamed A. Megahed, et al. · Pharmaceutics · 28

Influence of Surface-Modification via PEGylation or Chitosanization of Lipidic Nanocarriers on In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Apixaban

2023 · Mohamed F. Zaky, Taha M. Hammady, et al. · Pharmaceutics · 25

Stimuli Responsive Drug Delivery Systems: Types, Mechanisms, and Pharmaceutical Applications

2025 · Mohamed F. Zaky, Abdelrahman I. Othman, et al. · ERU Research Journal · 1

Synthesis and Biological Evaluation of New Pyrrolotacrines for the Treatment of Alzheimer’s Disease

2019 · Hanadi Y. Medrasi, Abdellatif M. Salaheldin, et al. · 1

Surface modified/controlled release amikacin-loaded lipidic-based hybrid nanovesicles: Quality by Design (QbD) endorsed fabrication and pharmacokinetic assessment of a BCS Class III drug

2026 · Hossam S. El-Sawy, Mohammed Amran, et al. · Journal of Drug Delivery Science and Technology

Enhanced efficacy and bioavailability of amikacin-loaded niosomal nanovesicles based on Low-HLB amphiphiles: In vitro/ex vivo/in vivo studies

2025 · Mohamed F. Zaky, Mohamed H. Desoqi, et al. · Journal of Drug Delivery Science and Technology

Works count: 6

Citation count: 55

H-index: 2

I10-index: 2